POST-TREATMENT LYME DISEASE SYNDROME
Clinical trials for POST-TREATMENT LYME DISEASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POST-TREATMENT LYME DISEASE SYNDROME trials appear
Sign up with your email to follow new studies for POST-TREATMENT LYME DISEASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a clot-busting enzyme ease long COVID and chronic fatigue?
Symptom relief Recruiting nowThis early-stage study tests lumbrokinase, an enzyme that breaks down blood clots, in 120 adults with Long COVID, post-treatment Lyme disease syndrome, or ME/CFS. Participants rate their overall health before and after treatment to see if the enzyme improves quality of life. The …
Matched conditions: POST-TREATMENT LYME DISEASE SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated May 26, 2026 06:05 UTC
-
New headset aims to ease lingering lyme pain
Symptom relief Recruiting nowThis study tests a wearable device called the Sana Pain Reliever (Sana PR) to see if it can reduce chronic pain in people with Post-treatment Lyme Disease Syndrome. About 20 participants will use the device at home for 15 minutes at a time over 14 weeks. The device uses flashing …
Matched conditions: POST-TREATMENT LYME DISEASE SYNDROME
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated May 26, 2026 04:38 UTC
-
Massive study aims to unlock secrets of brain inflammation diseases
Knowledge-focused Recruiting nowThis study collects health information from up to 10,000 people with conditions like Long COVID, ME/CFS, and autoimmune diseases. Participants use a phone app to share symptoms, wearables data, and lifestyle details. The goal is to help researchers better understand these illness…
Matched conditions: POST-TREATMENT LYME DISEASE SYNDROME
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC